Royal Society prize for Professor Mark Pepys
28 June 2007
Professor Mark Pepys, Head of Medicine at the Hampstead Campus and the Royal Free Hospital, has been awarded The Royal Society GlaxoSmithKline Prize for his work which first identified particular proteins as therapeutic targets and his design of new drugs with potential use in amyloidosis, Alzheimer's disease and cardiovascular disease.
Professor Pepys discovered the involvement of two blood proteins, serum amyloid P component and C‑reactive protein, in various important human diseases. He then invented new drugs, one of which is already being tested in patients, which specifically remove these harmful proteins from the blood by a novel mechanism.
Professor Pepys said: "It is a great honour to be recognised by the Royal Society, especially at this exciting time in the research. The new drugs are very promising and we are trying to progress them into clinical trials as fast as possible."
To find out more about the prize, and to read previous UCL news and press releases reporting on Professor Pepys' research, use the links at the bottom of the article.